In This Section
- News by Topic
- Media Resources
- University Events
- 5K Race for Humanity
- Advances in Pharmacy Practice
- Alumni Reunion Weekend
- Continuing Pharmacy Education
- Discover Series
- Family Fall Fest
- Founders’ Day
- Graduate Student Orientation
- Healthy Lifestyles Social Media Business Competition
- Lois K. Cohen Lecture Series
- Making the Connections
- Misher Festival of Fine Arts and Humanities
- MLK Day of Service
- Patricia Leahy Memorial Lecture
- Pharmacy-Based Immunization Delivery Training
- Philadelphia Science Festival
- REEP Annual Symposium and Networking Event
- Research Day
- Undergraduate Research Symposium
- Welcome Week
- Welcome Receptions for Dr. Paul Katz
- USciences in the News
- The Bulletin Alumni Magazine
- The Insider Newsletter Signup
USciences Professor Authors Textbook on Drug Discoveries for Treatment of Alzheimer's Disease
Written by Jenna Pizzi
Published on October 25, 2016
Dr. Adeboye Adejare, center, presents his book "Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease" to Provost Dr. Peter Miller, left, and President Dr. Paul Katz, right.
Adeboye Adejare PhD, professor of pharmaceutical sciences, is editor and author of a new book, Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer’s Disease.
The book, which published its first edition in September, aims to improve drug discovery and development for neurodegenerative disorders by focusing on current knowledge and strategies in Alzheimer’s disease.
It provides a compilation of chemical considerations required in drug discovery, examines different classes of compounds currently being used in discovery and development stages, and explores in vitro and in vivo models with respect to their ability to translate these models to human conditions.
The book also seeks to distill the most significant information across multiple areas of Alzheimer’s disease research to provide a single, comprehensive, and balanced resource, Dr. Adejare said.
Through its coverage of the latest research in targeted drug design, preclinical studies, and mouse and rat models, the book is a must-have resource for all pharmaceutical scientists, pharmacologists, neuroscientists, and clinical researchers working in this area. It illustrates why these drugs tend to fail at the clinical stage, and examines Alzheimer’s Disease within the overall context of improving the drug discovery process for the treatment of neurodegenerative disorders.
In addition to Dr. Adejare, several others affiliated with USciences were involved in the book. Faculty contributors include Dr. Steven Moelter, Dr. Jennifer Newell-Caito, Laura Finn, and Dr. Zeynep Ates-Alagoz. Alumni Dr. Adegoke Adeniji and Dr. Jason Wallach contributed.
In addition, graduate students Mohammed Alamri, Triastan Colestock and Maura Sheerin also contributed to the book.
To learn more or to purchase a copy of Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer’s Disease (ISBN 978-0-12-802810-0), visit store.elsevier.com. The book is also available for purchase from Amazon and Barnes and Noble in both hardcover and electronic formats.
Categories: Feature Story, Announcement, News, Alumni, Faculty, Students, Academics, Research, Philadelphia College of Pharmacy, Department of Pharmaceutical Sciences, Department of Pharmacy Practice, Pharmaceutical Sciences, Pharmaceutics, Pharmacology and Toxicology, Pharmacy, Pharmacy Administration, Pharmaceutical Sciences Homepage